These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26200834)

  • 1. Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Study.
    Pérez T; Makrestsov N; Garatt J; Torlakovic E; Gilks CB; Mallett S
    Appl Immunohistochem Mol Morphol; 2016; 24(10):679-687. PubMed ID: 26200834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an evidence-based approach to external quality assurance for breast cancer hormone receptor immunohistochemistry: comparison of reference values.
    Makretsov N; Gilks CB; Alaghehbandan R; Garratt J; Quenneville L; Mercer J; Palavdzic D; Torlakovic EE; ;
    Arch Pathol Lab Med; 2011 Jul; 135(7):874-81. PubMed ID: 21732777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
    Terry J; Torlakovic EE; Garratt J; Miller D; Köbel M; Cooper J; Bahzad S; Pilavdzic D; O'Malley F; O'Brien AE; SenGupta S; Alport E; Têtu B; Knight B; Pettigrew NM; Berendt R; Wolber R; Trotter MJ; Riddell RH; Gaboury L; Elms F; Magliocco A; Barnes P; Gown AM; Gilks CB
    Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):375-82. PubMed ID: 19363444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.
    Dekker TJ; ter Borg S; Hooijer GK; Meijer SL; Wesseling J; Boers JE; Schuuring E; Bart J; van Gorp J; Bult P; Riemersma SA; van Deurzen CH; Sleddens HF; Mesker WE; Kroep JR; Smit VT; van de Vijver MJ
    Breast Cancer Res Treat; 2015 Jul; 152(2):247-52. PubMed ID: 26041687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Assessment of Immunohistochemistry Laboratory Performance by Measuring Analytic Response Curves and Limits of Detection.
    Sompuram SR; Vani K; Schaedle AK; Balasubramanian A; Bogen SA
    Arch Pathol Lab Med; 2018 Jul; 142(7):851-862. PubMed ID: 29595317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer care Ontario guideline recommendations for hormone receptor testing in breast cancer.
    Nofech-Mozes S; Vella ET; Dhesy-Thind S; Hanna WM
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):684-96. PubMed ID: 22608362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The laboratory score/reference method score ratio (LSRSR) is a novel tool for monitoring laboratory performance in immunohistochemistry proficiency testing of hormone receptors in breast cancer: the CIQC experience.
    Cheung CC; Neufeld H; Lining LA; Pilavdzic D; Copete M; Garratt J; Gilks B; Torlakovic EE
    Am J Clin Pathol; 2011 Jul; 136(1):67-73. PubMed ID: 21685033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptor expression in breast cancer: postanalytical issues.
    Lee M; Lee CS; Tan PH
    J Clin Pathol; 2013 Jun; 66(6):478-84. PubMed ID: 23526546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptor testing in breast carcinoma: concordance of results between local and reference laboratories in Brazil.
    Wludarski SC; Lopes LF; Duarte IX; Carvalho FM; Weiss L; Bacchi CE
    Sao Paulo Med J; 2011; 129(4):236-42. PubMed ID: 21971899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment accuracy of core needle biopsy for hormone receptors in breast cancer: a meta-analysis.
    Li S; Yang X; Zhang Y; Fan L; Zhang F; Chen L; Zhou Y; Chen X; Jiang J
    Breast Cancer Res Treat; 2012 Sep; 135(2):325-34. PubMed ID: 22527109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates.
    Marinšek ZP; Nolde N; Kardum-Skelin I; Nizzoli R; Onal B; Rezanko T; Tani E; Ostović KT; Vielh P; Schmitt F; Kocjan G
    Cytopathology; 2013 Feb; 24(1):7-20. PubMed ID: 23082931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-laboratory quality control of estrogen and progesterone receptor assays in breast cancer tissue using lyophilised cytosols.
    Ryan ED; Clark AF; Mobbs BG; Ooi TC; Sutherland DJ; Tustanoff ER
    Clin Biochem; 1985 Feb; 18(1):20-6. PubMed ID: 3986988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and progesterone receptors in breast cancer.
    Yip CH; Rhodes A
    Future Oncol; 2014 Nov; 10(14):2293-301. PubMed ID: 25471040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
    Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control for the immunohistochemical demonstration of oestrogen and progesterone receptors.
    Nicholson RI; Leake R
    J Clin Pathol; 2000 Apr; 53(4):247. PubMed ID: 10823118
    [No Abstract]   [Full Text] [Related]  

  • 17. Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis.
    Chen X; Yuan Y; Gu Z; Shen K
    Breast Cancer Res Treat; 2012 Aug; 134(3):957-67. PubMed ID: 22370627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical profile of the estrogen and progesterone receptors in mammary benign lesions.
    Moise M; Răducan S; Boscu A; Jianu A; Niculescu M; Selaru M; Motoc A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):875-82. PubMed ID: 23272545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.